Montelukast Prescribing at WOODSTOCK BOWER GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,607
Total Quantity
44.0K
NHS Cost
£2.1K
vs National Avg
+134.7%
WOODSTOCK BOWER GROUP PRACTICE prescribed 1,607 items of Montelukast over the last 12 months at a cost of £2,116 to the NHS. This is 134.7% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
132
Jul 2026
129
Jul 2026
145
Jul 2026
139
Jul 2026
142
Jul 2026
143
Jul 2026
129
Jul 2026
136
Jul 2026
133
Jul 2026
130
Jul 2026
118
Jul 2026
131
Prescribing Details
| Total Items | 1,607 |
|---|---|
| Total Quantity | 43,960 |
| Total NHS Cost | £2,116 |
| Presentations | 4 different forms |
| vs National Average | +134.7% |
Montelukast Prescribing Comparison
| This practice | 1,607 items |
|---|---|
| National average per practice | 685 items |
| Difference | +134.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.